Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Wednesday October 24, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley Monk, MD, FACOG, FACS, Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine, discuss BRCA1+ ovarian patients, PARP inhibitors and the results of the SOLO-1 clinical trial

Featured Videos

Shirish Madhav Gadgeel, MBBS, on treating non-squamous NSCLC patients expressing high PD-L1

Shirish Madhav Gadgeel, MBBS, on treating patients who have already received PD-L1 targeting agents

Paul G. Richardson, MD, regarding the updated FORTE trial data in multiple myeloma